<DOC>
	<DOCNO>NCT01826747</DOCNO>
	<brief_summary>The objective test hypothesis luteal phase support vaginal progesterone lead high clinical pregnancy rate ( primary outcome ) live birth rate ( secondary outcome ) compare luteal phase support program intrauterine insemination ( IUI ) control ovarian stimulation gonadotrophin . Additionally , length luteal phase record ( secondary outcome ) order detect luteal phase defects/insufficiencies absence luteal phase suppletion well luteal phase prolongation case luteal phase support may burden patient wait outcome treatment .</brief_summary>
	<brief_title>Intrauterine Insemination Luteal Fase Support</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Patients indication IUI : unexplained infertility mild male factor infertility minimalmild endometriosis Women : first IUI cycle ever normal ovulatory cycle ( 2632d ) age &lt; 43 , BMI≤30 presence least one patent tube hysterosalpingography and/or laparoscopy normal uterine cavity ( ultrasound , hysterosalpingography , laparoscopy ) Men : Total motile count ≥ 5 Million/ml capacitation Patients contraindication pregnancy , infertility progesterone use .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>intrauterine insemination</keyword>
	<keyword>luteal phase</keyword>
	<keyword>gonadotrophin</keyword>
</DOC>